Sign inJoin waitlistJoin the waitlist

Lubna Chaudhary

Associate Professor · Medical College of Wisconsin Affiliated Hospitals, Inc

Credentials: · · · ·

History

Medical College of Wisconsin Affiliated Hospitals, Inc
Present

Hematology and Medical Oncology
Medical College of Wisconsin Affiliated Hospitals, Inc
2013–2015
Hematology and Medical Oncology
West Virginia University School of Medicine
2012–2013
Internal Medicine
West Virginia University School of Medicine
2009–2010
KING EDWARD MED COLL, LAHORE, WEST PAKISTAN
2001–2005

Research

Triple-Negative Breast Cancer: Who Should Receive Neoadjuvant Chemotherapy?
Review · Surgical Oncology Clinics of North America · 2018 · First of 3 authors · 124 citations
Methylation signatures as biomarkers for non-invasive early detection of breast cancer: A systematic review of the literature
Systematic review or meta-analysis · Cancer Genetics · 2024 · 45 citations
Relevance of progesterone receptor immunohistochemical staining to Oncotype DX recurrence score
Hematology/Oncology and Stem Cell Therapy · 2016 · First of 5 authors · Corresponding · 39 citations

Sailaja Kamaraju
11 papers
Yee Cheng
9 papers
Christopher Chitambar
8 papers
Amanda Kong
7 papers
Chandler Cortina
6 papers
Julie Jorns
6 papers
John Burfeind
5 papers
AC
Adrienne Cobb
3 papers
AR
Arya Roy
3 papers · 3 as a fellow
Caitlin Patten
3 papers
Carmen Bergom
3 papers
Jame Abraham
3 papers

Grants

Quantitative Analyses of HER2 Upregulation in Luminal Breast Cancer in Response to Neoadjuvant Endocrine Therapy
National Cancer Institute · R03
Contact PI · $170K · Medical College of Wisconsin
2021–2023

Clinical trials

Cancer Lipidome Adaptation and Resculping Through Omega-3 PUFAs in Breast Tumors
Principal investigator · Not yet recruiting · Phase 2
Medical College of Wisconsin
2026–2028
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
Principal investigator · Recruiting · Phase 2
Medical College of Wisconsin
2024–2029
Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer
Principal investigator · Active not recruiting · Phase 2
Medical College of Wisconsin
2020–2030
Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer
Principal investigator · Completed · Phase 2
Medical College of Wisconsin
2017–2025